Side-by-side comparison of AI visibility scores, market position, and capabilities
Global flavor leader with $6.7B revenue; McCormick, French's, Lawry's, and Old Bay brands spanning retail spices and custom flavors for food manufacturers competing with Kraft Heinz.
McCormick & Company is a global leader in flavor — producing and marketing spices, herbs, seasonings, condiments, and flavoring solutions for consumers, food manufacturers, and foodservice operators in 150+ countries. Listed on NYSE (NYSE: MKC) and headquartered in Hunt Valley, Maryland, McCormick generates approximately $6.7 billion in annual net revenue and owns iconic brands including McCormick (retail spices and seasonings), French's (mustard and crispy fried onions), Lawry's (seasoning salts and marinades), Old Bay (seafood seasoning), and Stubb's (BBQ sauces).\n\nMcCormick's two segments serve distinct markets: Consumer (retail spices, herbs, recipe mixes, and condiments sold at grocery and mass retail) and Flavor Solutions (custom flavor development and seasonings for food manufacturers and restaurant chains). The Flavor Solutions segment serves customers like McDonald's, Subway, and major CPG food manufacturers who need proprietary flavors for their products — this B2B segment provides revenue stability even as consumer trends shift. McCormick's 2017 acquisition of French's and Frank's RedHot from Reckitt Benckiser for $4.2 billion significantly expanded the condiment portfolio.\n\nIn 2025, McCormick competes with Kraft Heinz (condiments), B&G Foods, and private label for retail spice and condiment market share, and with Givaudan, IFF, and Symrise for the flavor solutions market. The post-COVID inflationary environment affected McCormick's margins as commodity spice costs rose, with 2023-2024 focused on margin recovery through pricing and efficiency. The 2025 strategy focuses on premiumization in retail (growing Lawry's, Old Bay brand extensions), international expansion in Asia and Latin America, and growing the Flavor Solutions business with QSR and processed food manufacturer customers pursuing flavor innovation.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.